Rafferty Asset Management »

Verve Therapeutics shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.2M 320k 13.26
2023-06-30 $5.2M 280k 18.75
2023-03-31 $3.8M 263k 14.42
2022-12-31 $7.2M 373k 19.35
2022-09-30 $6.1M 179k 34.35
2022-03-31 $4.2M 185k 22.82
2021-12-31 $5.3M 143k 36.87